Imaging Technology

JANUARY 5, 2024

The PSMA Alpha-PET DoubLET platform technology represents a potential leap forward in the field of prostate cancer diagnostics and treatment. We focused on diagnostic accuracy, patient tolerance and convenience. milla1cf Fri, 01/05/2024 - 11:21 January 5, 2024 — Perspective Therapeutics, Inc.

Radiopharmaceuticals 76

Radiopharmaceuticals Clinic Nuclear Medicine Radiation 76

Imaging Technology

JUNE 12, 2024

milla1cf Wed, 06/12/2024 - 21:58 June 12, 2024 — Cathy Sue Cutler, PhD, FSNMMI , chair of the Isotope Research and Production Department at Brookhaven National Laboratory in Upton, New York, has been named as president for the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

Nuclear Medicine 104

Nuclear Medicine Radiopharmaceuticals Education Government 104

Diagnostic Imaging

JUNE 28, 2023

In a recent interview at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference in Chicago, Phillip Kuo, M.D.,

Radiopharmaceuticals 61

Radiopharmaceuticals Nuclear Medicine Imaging 61

Imaging Technology

APRIL 5, 2024

milla1cf Fri, 04/05/2024 - 11:31 April 5, 2024 — RLS Radiopharmacies , America’s only Joint Commission-accredited radiopharmacy network, today announced it has expanded its radiopharmaceutical contract development and manufacturing (rCDMO) capabilities by entering into a strategic agreement with global isotope technology leader Eckert & Ziegler.

Radiopharmaceuticals 52

Radiopharmaceuticals Radiation Oncology Radiation Quality and Compliance 52

AuntMinnie

MARCH 26, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.

Nuclear Medicine 122

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 122

Imaging Technology

JUNE 15, 2023

The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use.

Radiopharmaceuticals 84

Radiopharmaceuticals Pharmaceutical Nuclear Medicine PET Scan 84

Imaging Technology

JANUARY 5, 2024

milla1cf Fri, 01/05/2024 - 11:32 January 5, 2024 — NorthStar Medical Radioisotopes, LLC , a global innovator in development, production and commercialization of radiopharmaceuticals used to detect and treat cancer and other serious diseases, and Curadh MTR Inc. Chief Executive Officer of NorthStar Medical Radioisotopes.

Radiopharmaceuticals 52

Radiopharmaceuticals Medical Nuclear Medicine Pharmaceutical 52

AuntMinnie

JUNE 14, 2024

Nuclear medicine injection extravasations and medical events will be the focus of the Advisory Committee on the Medical Uses of Isotopes (ACMUI)'s public teleconference on June 17. That might do away with diagnostic concerns, Flannery noted.

Nuclear Medicine 52

Nuclear Medicine Radiation Radiopharmaceuticals Medical 52

AuntMinnie

JUNE 20, 2024

Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. Since 2013 we've had several more radiopharmaceutical therapies get FDA approval.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Radiation Health Science 52

AuntMinnie

APRIL 4, 2024

A decade ago, only a few radiopharmaceutical agents were used to help treat cancer patients. He also helped lead the theranostics conference at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2024 midwinter meeting. However, few freestanding theranostics centers exist today. Hope added.

Nuclear Medicine 87

Nuclear Medicine Radiation Oncology Nursing Radiation 87

AuntMinnie

JUNE 10, 2024

Cathy Sue Cutler, PhD, has been named president of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). As president, I will continue to work to support the Facilitating Innovative Nuclear Diagnostics (FIND) Act of 2023, which will ensure equitable access to care and treatment for patients.”

Nuclear Medicine 40

Nuclear Medicine Radiopharmaceuticals Education Diagnostic 40

Open Medscience

NOVEMBER 4, 2023

Cyclotrons advance nuclear medicine by efficiently producing key radionuclides for diagnostics and treatment within hospital settings. The post The Pivotal Role of Cyclotrons in Radionuclide Production appeared first on Open Medscience.

Nuclear Medicine 52

Nuclear Medicine Hospital Diagnostic Radiopharmaceuticals 52

Imaging Technology

JUNE 21, 2023

POSLUMA is now commercially available through multiple radiopharmacies of PETNET Solutions, the primary manufacturer and commercial distributor for Blue Earth Diagnostics in the United States. Chief Executive Officer of Blue Earth Diagnostics Ltd. Blue Earth Diagnostics is at Booth 6025 and PETNET Solutions is at Booth 6075.

Diagnostic 72

Diagnostic Radiopharmaceuticals Imaging Medicare 72

Imaging Technology

JUNE 29, 2023

milla1cf Thu, 06/29/2023 - 21:10 June 29, 2023 — Blue Earth Therapeutics , a Bracco company and emerging leader in the development of innovative next generation therapeutic radiopharmaceuticals, today announced highlights from early clinical and preclinical studies of 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1 177Lu-rhPSMA-10.1

Clinic 79

Clinic Nuclear Medicine Radiopharmaceuticals Radiation 79

TTG Imaging Solutions

AUGUST 1, 2023

Martin Shirley was appointed the role of TTG Imaging Solutions Executive Vice President Sales, Marketing & Clinical Operations in April of 2023 as part of TTG Imaging Solutions acquisition of Digirad Health, Inc and its subsidiaries Digirad Diagnostic Imaging, Inc and Digirad Imaging Solution, Inc. The post Martin B.

Nuclear Medicine 40

Nuclear Medicine Clinic Radiopharmaceuticals Diagnostic Imaging 40

TTG Imaging Solutions

AUGUST 1, 2023

Martin Shirley was appointed the role of TTG Imaging Solutions Executive Vice President Sales, Marketing & Clinical Operations in April of 2023 as part of TTG Imaging Solutions acquisition of Digirad Health, Inc and its subsidiaries Digirad Diagnostic Imaging, Inc and Digirad Imaging Solution, Inc. The post Martin B.

Nuclear Medicine 40

Nuclear Medicine Clinic Radiopharmaceuticals Diagnostic Imaging 40

TTG Imaging Solutions

SEPTEMBER 28, 2021

Be sure to visit us at our virtual booth Thursday, September 30 through Saturday, October 2 to learn more about our complete nuclear medicine and molecular imaging solutions. Request a meeting with one of our Regional Sales Managers at sales@ttgimagingsolutions.com.

Nuclear Medicine 52

Nuclear Medicine Imaging Radiopharmaceuticals Diagnostic Imaging 52

TTG Imaging Solutions

OCTOBER 27, 2021

Be sure to visit us at our virtual booth Saturday, October 30 and Sunday, October 31 to learn more about our complete nuclear medicine and molecular imaging solutions. Request a meeting with one of our Regional Sales Managers at sales@ttgimagingsolutions.com. Discover how we can create a partnership that exceeds your expectations.

Nuclear Medicine 52

Nuclear Medicine Imaging Radiopharmaceuticals Diagnostic Imaging 52

TTG Imaging Solutions

FEBRUARY 17, 2022

About TTG Imaging Solutions TTG Imaging Solutions is your partner for nuclear medicine and molecular imaging solutions that includes equipment sales, nationwide service, parts, turnkey diagnostic imaging, and radiopharmaceuticals.

Nuclear Medicine 52

Nuclear Medicine Imaging Radiopharmaceuticals Diagnostic Imaging 52

Open Medscience

NOVEMBER 9, 2023

The post Unveiling the Complex Etiology and Innovative Diagnostic Approaches in Alzheimer’s Disease appeared first on Open Medscience. Alzheimer's disease stems from genetic mutations and lifestyle factors, leading to brain plaque accumulation and dementia.

Disease 59

Disease Diagnostic Nuclear Medicine Radiopharmaceuticals 59

Imaging Technology

JUNE 20, 2024

More than half of the world’s population is underserved and lacks access to essential health services, and two-thirds have no access to diagnostic imaging. In the hands of clinicians, these tools help make the practice of precision care more accessible and aim to help improve patient outcomes globally.”

Healthcare 78

Healthcare Healthcare Nuclear Medicine Computed Tomography 78

TTG Imaging Solutions

JANUARY 9, 2022

About TTG Imaging Solutions TTG Imaging Solutions is your partner for nuclear medicine and molecular imaging solutions that includes equipment sales, nationwide service, parts, turnkey diagnostic imaging, and radiopharmaceuticals. Request a meeting with one of our Regional Sales Managers at sales@ttgimagingsolutions.com.

Nuclear Medicine 52

Nuclear Medicine Radiopharmaceuticals Imaging Diagnostic Imaging 52

AuntMinnie

JANUARY 19, 2024

This can only be accomplished with a combination of innovative diagnostic, treatment, and monitoring technology that can enable timely interventions and personalized treatment plans. More accurate diagnostic and monitoring tools can also help manage the high cost of new therapies by preventing the misuse of expensive treatments.

Disease 52

Disease Medicare Imaging PET Scan 52

Imaging Technology

APRIL 3, 2023

produced, non-uranium based Mo-99 for use in diagnostic imaging. Mr. Merrick continued, “Demand for therapeutic radiopharmaceuticals is increasing rapidly. NorthStar has further deepened and broadened our business platform with the recent establishment of a full-scale radiopharmaceutical CDMO/CMO services unit.

Medical 79

Medical Radiopharmaceuticals Pharmaceutical Radiation 79

TTG Imaging Solutions

MAY 5, 2023

operates a diagnostic imaging turnkey business and serves as an OEM and service provider for a well-respected portfolio of fixed and mobile solid-state nuclear medicine cameras. headquartered in Suwanee, GA. The acquisition closed on May 4, 2023. Digirad Health, Inc.

Imaging 52

Imaging Radiopharmaceuticals Radiation Oncology Nuclear Medicine 52

TTG Imaging Solutions

NOVEMBER 1, 2021

PITTSBURGH, PA (November 1, 2021) – TTG Imaging Solutions, LLC (TTG) announced today executive leadership changes that will drive the company’s next phase of growth following its 9th acquisition in 2 years of Medical Imaging Technologies, an Akron, Ohio based nuclear medicine equipment and service organization.

Nuclear Medicine 52

Nuclear Medicine Imaging Radiopharmaceuticals Medical Imaging 52

Open Medscience

JANUARY 29, 2024

SPECT imaging, by combining functional and anatomical insights, significantly enhances diagnostic accuracy in various medical fields. The post The Future of SPECT Imaging and Emerging Technological Advances appeared first on Open Medscience.

Imaging 52

Imaging Diagnostic Medical Nuclear Medicine 52

Open Medscience

MAY 14, 2024

Positron Emission Tomography Imaging has advanced with cutting-edge technologies, enhancing diagnostic accuracy and expanding clinical applications dramatically. The post Breakthroughs in Positron Emission Tomography Imaging appeared first on Open MedScience.

Imaging 52

Imaging Diagnostic Clinic Nuclear Medicine 52

Open Medscience

DECEMBER 8, 2018

The most commonly used medical radioisotope in diagnostic procedures is technetium-99m. The post What is myocardial perfusion imaging of the heart? appeared first on Open Medscience.

Imaging 52

Imaging Diagnostic Medical Nuclear Medicine 52